These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 21763166

  • 1. Development of in silico models for pyrazoles and pyrimidine derivatives as cyclin-dependent kinase 2 inhibitors.
    Wang F, Ma Z, Li Y, Zhu S, Xiao Z, Zhang H, Wang Y.
    J Mol Graph Model; 2011 Sep; 30():67-81. PubMed ID: 21763166
    [Abstract] [Full Text] [Related]

  • 2. An in silico exploration of the interaction mechanism of pyrazolo[1,5-a]pyrimidine type CDK2 inhibitors.
    Li Y, Gao W, Li F, Wang J, Zhang J, Yang Y, Zhang S, Yang L.
    Mol Biosyst; 2013 Sep; 9(9):2266-81. PubMed ID: 23864105
    [Abstract] [Full Text] [Related]

  • 3. Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.
    Dhanachandra Singh Kh, Karthikeyan M, Kirubakaran P, Nagamani S.
    J Mol Graph Model; 2011 Sep; 30():186-97. PubMed ID: 21831680
    [Abstract] [Full Text] [Related]

  • 4. Exploring the structure requirement for PKCθ inhibitory activity of pyridinecarbonitrile derivatives: an in silico analysis.
    Li Y, Hao M, Ren H, Zhang S, Wang X, Ma M, Li G, Yang L.
    J Mol Graph Model; 2012 Apr; 34():76-88. PubMed ID: 22306416
    [Abstract] [Full Text] [Related]

  • 5. Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors.
    Dwyer MP, Paruch K, Alvarez C, Doll RJ, Keertikar K, Duca J, Fischmann TO, Hruza A, Madison V, Lees E, Parry D, Seghezzi W, Sgambellone N, Shanahan F, Wiswell D, Guzi TJ.
    Bioorg Med Chem Lett; 2007 Nov 15; 17(22):6216-9. PubMed ID: 17904366
    [Abstract] [Full Text] [Related]

  • 6. Molecular modeling studies to characterize N-phenylpyrimidin-2-amine selectivity for CDK2 and CDK4 through 3D-QSAR and molecular dynamics simulations.
    Chohan TA, Chen JJ, Qian HY, Pan YL, Chen JZ.
    Mol Biosyst; 2016 Apr 15; 12(4):1250-68. PubMed ID: 26883408
    [Abstract] [Full Text] [Related]

  • 7. 3D-QSAR CoMFA study on indenopyrazole derivatives as cyclin dependent kinase 4 (CDK4) and cyclin dependent kinase 2 (CDK2) inhibitors.
    Singh SK, Dessalew N, Bharatam PV.
    Eur J Med Chem; 2006 Nov 15; 41(11):1310-9. PubMed ID: 16890327
    [Abstract] [Full Text] [Related]

  • 8. Molecular docking and MD simulation studies of 4-thiazol-N-(pyridin-2-yl)pyrimidin-2-amine derivatives as novel inhibitors targeted to CDK2/4/6.
    Liang JD, Zhang YE, Qin F, Chen WN, Jiang WM, Fang Z, Liang XL, Zhang Q, Li J.
    J Cancer Res Clin Oncol; 2024 Jun 10; 150(6):302. PubMed ID: 38856753
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H, Zhang H.
    J Mol Graph Model; 2010 Aug 24; 29(1):54-71. PubMed ID: 20471293
    [Abstract] [Full Text] [Related]

  • 15. 3D-QSAR CoMFA and CoMSIA study on benzodipyrazoles as cyclin dependent kinase 2 inhibitors.
    Dessalew N, Singh SK.
    Med Chem; 2008 Jul 24; 4(4):313-21. PubMed ID: 18673142
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
    Ibrahim DA, El-Metwally AM.
    Eur J Med Chem; 2010 Mar 24; 45(3):1158-66. PubMed ID: 20045222
    [Abstract] [Full Text] [Related]

  • 18. Computational study on the interaction of N1 substituted pyrazole derivatives with B-raf kinase: an unusual water wire hydrogen-bond network and novel interactions at the entrance of the active site.
    Alzate-Morales JH, Vergara-Jaque A, Caballero J.
    J Chem Inf Model; 2010 Jun 28; 50(6):1101-12. PubMed ID: 20524689
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.